Showing results (431-440 of 528) with videos related to
Sort By:
Pageof 53
Journal of Acquired Immune Deficiency Syndromes (1999)|October 5, 2006
Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypesSurender Khurana, James Needham, Susan Park, et al.Immunity|July 16, 2021
COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challengeAnthony T DiPiazza, Sarah R Leist, Olubukola M Abiona, et al.Science Translational Medicine|April 19, 2023
An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humansSarah F Andrews, Lauren Y Cominsky, Geoffrey D Shimberg, et al.Biorxiv : the Preprint Server for Biology|June 26, 2025
Functional, Immunogenetic, and Structural Convergence in Influenza Immunity between Humans and MacaquesMaya Sangesland, Ning Li, Yaroslav Tsybovsky, et al.Science (New York, N.Y.)|September 19, 2015
Dengue viruses cluster antigenically but not as discrete serotypesLeah C Katzelnick, Judith M Fonville, Gregory D Gromowski, et al.Plos Medicine|January 25, 2018
Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adultsMartin R Gaudinski, Emily E Coates, Katherine V Houser, et al.The Journal of Infectious Diseases|October 18, 2015
Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083Stephen R Walsh, Zoe Moodie, Andrew J Fiore-Gartland, et al.Nature Communications|July 29, 2015
Evaluation of candidate vaccine approaches for MERS-CoVLingshu Wang, Wei Shi, M Gordon Joyce, et al.The Journal of Infectious Diseases|April 16, 2022
Recurrent Respiratory Syncytial Virus Infection in a CD14-Deficient PatientSjanna B Besteman, Emily Phung, Henriette H M Raeven, et al.Science (New York, N.Y.)|February 27, 2016
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibodyDavide Corti, John Misasi, Sabue Mulangu, et al.Pageof 53